Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sinovac Biotech Ltd (SVA)

Sinovac Biotech Ltd (SVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,919
  • Shares Outstanding, K 57,019
  • Annual Sales, $ 246,050 K
  • Annual Income, $ 44,930 K
  • 60-Month Beta 0.35
  • Price/Sales 1.83
  • Price/Cash Flow N/A
  • Price/Book 1.70
Trade SVA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/11/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.25 +3.52%
on 02/22/19
6.69 -3.29%
on 02/12/19
-0.03 (-0.46%)
since 01/22/19
3-Month
5.73 +12.91%
on 12/21/18
7.50 -13.73%
on 12/03/18
-0.73 (-10.14%)
since 11/21/18
52-Week
5.73 +12.91%
on 12/21/18
8.75 -26.06%
on 03/22/18
-1.65 (-20.32%)
since 02/22/18

Most Recent Stories

More News
Asia Today: Philippine cases hit 500K amid vaccine struggles

MANILA, Philippines (AP) — Coronavirus infections in the Philippines have surged past 500,000 in a new bleak milestone with the government facing criticism for failing to immediately launch a vaccination...

SVA : 6.47 (-0.31%)
The Latest: China says COVID-19 hospitalizations above 1,000

BEIJING — China says it is now treating more than 1,000 people for COVID-19 as numbers of cases continue to surge in the country’s north.

SVA : 6.47 (-0.31%)
JNJ : 170.48 (+2.71%)
Turkey approves China-based Sinovac vaccine's emergency use

ANKARA, Turkey (AP) — Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotech Ltd. on Wednesday, paving the way for the rollout for Turkey’s...

SVA : 6.47 (-0.31%)
Indonesia starts mass COVID vaccinations over vast territory

JAKARTA, Indonesia (AP) — Indonesian President Joko Widodo received the first shot of a Chinese-made coronavirus vaccine Wednesday after the government authorized it for emergency use and began efforts...

SVA : 6.47 (-0.31%)
PFE : 37.31 (+0.08%)
Indonesia green-lights emergency use of Chinese vaccine

JAKARTA, Indonesia (AP) — Indonesia’s Food and Drug Authority on Monday green-lighted emergency use of the COVID-19 vaccine produced by China-based Sinovac Biotech Ltd., with vaccinations of high-risk...

SVA : 6.47 (-0.31%)
Chinese drugmaker: Vaccine 79.3% effective in final tests

BEIJING (AP) — A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer...

PFE : 37.31 (+0.08%)
MRNA : 151.85 (+3.30%)
SVA : 6.47 (-0.31%)
1Globe Capital, the Largest Shareholder of Sinovac Biotech, Reached Agreement with SEC and Calls on All Stakeholders to Support Sinovac's COVID-19 Vaccine Program

1Globe Capital LLC ("1GlobeCap"), a principal and long-term shareholder of Sinovac Biotech (NASDAQ: SVA) ("Sinovac"), has reached agreement with the Securities and Exchange Commission ("SEC") to end investigation...

SVA : 6.47 (-0.31%)
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine

Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA)...

SVA : 6.47 (-0.31%)
India Vaccines Market Size 2020 Global Industry Updates, Leading Players ,Future Growth, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2025 | BMRC

: Rising burden of several infectious and non-infectious diseases, increasing government and non government support for vaccine development, and increasing Research and Underdevelopment likely to augment...

BMY : 64.44 (-0.60%)
CSLLY : 106.1500 (-0.57%)
DSNKY : 34.6350 (+0.07%)
DVAX : 6.17 (-5.80%)
MRK : 80.25 (-1.11%)
NVAX : 127.16 (-3.27%)
PFE : 37.31 (+0.08%)
SVA : 6.47 (-0.31%)
VRX.TO : 30.80 (-3.33%)
VBIV : 3.15 (-2.78%)
Sinovac: 3Q Earnings Snapshot

BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Monday reported third-quarter earnings of $11.2 million.

SVA : 6.47 (-0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 6.76
1st Resistance Point 6.62
Last Price 6.47
1st Support Level 6.29
2nd Support Level 6.10
3rd Support Level N/A

See More

52-Week High 8.75
Fibonacci 61.8% 7.60
Fibonacci 50% 7.24
Fibonacci 38.2% 6.88
Last Price 6.47
52-Week Low 5.73

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar